Rackspace Technology Reports Narrowed Losses, No Impairments in 2025 Amidst Continued Revenue Decline and Delisting Risk
RXT has more than doubled off its 52-week low of $0.393.
Summary
Rackspace Technology reported a significantly narrowed net loss and operating loss in 2025, with no goodwill or asset impairments, despite a continued decline in revenue. The company remains highly leveraged and faces an ongoing Nasdaq delisting risk.
Key Events · Earnings and Guidance · RXT
-
Significantly Narrowed Net Loss
Net loss improved to $225.8 million in 2025, a substantial reduction from $858.2 million in 2024 and $837.8 million in 2023.
-
Reduced Operating Loss
Loss from operations decreased significantly to $100.7 million in 2025, compared to $909.1 million in 2024.
-
No Goodwill or Asset Impairments in 2025
The company recorded no goodwill or asset impairment charges in 2025, a positive development following $714.9 million in goodwill impairment and $20.0 million in asset impairment in 2024, and similar large impairments in 2023.
-
Continued Revenue Decline
Revenue decreased by 1.9% to $2,685.7 million in 2025 from $2,737.1 million in 2024, continuing a downward trend from $2,957.1 million in 2023.
Analysis · RXT · Technology
This annual report provides the full audited financial results for 2025, confirming a significant reduction in net and operating losses compared to previous years, and notably, no goodwill or asset impairment charges. While revenue continues to decline, the improved profitability metrics and cash flow from operations suggest a more stable financial footing. However, the company remains highly leveraged, and the explicit disclosure of Nasdaq's $1.00 minimum bid price requirement highlights an ongoing material risk to investors. The detailed breakdown of the 2024 troubled debt restructuring also provides crucial context for the company's financial health.
At the time of this filing, RXT was trading at $2.04 on NASDAQ in the Technology sector, with a market capitalization of approximately $504.2M. The 52-week trading range was $0.39 to $2.74. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.